STEM CELL TREATMENT OF SCLERODERMA
Scleroderma is a chronic systemic autoimmune disease (primarily of the skin) characterized by fibrosis (or hardening), vascular alterations, and autoantibodies. There are two major forms:
Limited systemic sclerosis/scleroderma involves cutaneous manifestations that mainly affect the hands, arms and face. Additionally, pulmonary arterial hypertension may occur in up to one third of patients and is the most serious complication for this form of scleroderma.
Diffuse systemic sclerosis/scleroderma is rapidly progressing and affects a large area of the skin and one or more internal organs, frequently the kidneys, esophagus, heart and lungs. This form of scleroderma can be quite disabling. There are no treatments for scleroderma itself, but individual organ system complications are treated. Other forms of scleroderma include systemic sine scleroderma. Stem cells from bone marrow can reverse most of the symptoms. Adult stem cells can save your llife. Hematopoietic stem cell transplantation is currently being tested in prospective randomized controlled trials and appears to ‘reset’ autoimmunity in systemic sclerosis. Mesenchymal stem cells may have an immunomodulatory role in autoimmune disease. Patients treated with their own stem cell shown remarkable improvement in treating scleroderma.
Tony says, “Every day after I got my transplant, every day was getting better. Every day was like getting a new shot of life in your arm every day.”
And as of today, Tony has his health back again and he continues to improve. He’s running his construction business, working out at his exercise bike and says he’s back to about 80% of his original mobility.